{"name": "NanoCor Therapeutics",
 "permalink": "nanocor-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/nanocor-therapeutics",
 "homepage_url": "http://www.nanocorthx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "919-942-0252",
 "description": "",
 "created_at": "Wed Mar 17 11:24:32 UTC 2010",
 "updated_at": "Wed Mar 17 11:30:11 UTC 2010",
 "overview": "\u003Cp\u003ENanoCor Therapeutics is a biotechnology company founded to create a viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF).  The company was spun off from Askl\u00c3\u00aapios BioPharmaceutical, Inc. in November 2005.\u003C/p\u003E\n\n\u003Cp\u003ENanoCor\u00e2\u20ac\u2122s initial focus is the commercial development of a non-invasive treatment for CHF. NanoCor\u00e2\u20ac\u2122s therapeutic is comprised of the delivery of a proprietary gene developed at the Massachusetts General Hospital and the University of Cincinnati. The gene will be delivered with AskBio\u00e2\u20ac\u2122s proprietary Biological NanoParticle (BNP\u00e2\u201e\u00a2) and the Self-Complementary Vector technologies, which are derived from human adeno-associated virus vectors (rAAV).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0008/0676/80676v1-max-150x150.jpg"],
     [[250,
       52],
      "assets/images/resized/0008/0676/80676v1-max-250x250.jpg"],
     [[423,
       89],
      "assets/images/resized/0008/0676/80676v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.75M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.nanocorthx.com/PressReleases/MedtronicMakesEquityInvestment.pdf",
    "source_description": "Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc",
    "raised_amount": 3750000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 9,
    "funded_day": 10,
    "investments":
     [{"company":
        {"name": "Medtronic",
         "permalink": "medtronic",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0006/2291/62291v1-max-150x150.jpg"],
             [[222,
               60],
              "assets/images/resized/0006/2291/62291v1-max-250x250.jpg"],
             [[222,
               60],
              "assets/images/resized/0006/2291/62291v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "870 Martin Luther King Jr. Blvd",
    "address2": "",
    "zip_code": "27514",
    "city": "Chapel Hill",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        122],
       "assets/images/resized/0008/0677/80677v1-max-150x150.jpg"],
      [[250,
        204],
       "assets/images/resized/0008/0677/80677v1-max-250x250.jpg"],
      [[450,
        368],
       "assets/images/resized/0008/0677/80677v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}